Alzheimer’s disease (AD) progression involves deposition of β-amyloid (Aβ) plaques, neurofibrillary tangle deposits of hyperphosphorylated tau, and neurodegeneration most prominently in tau-affected brain regions [1–3]. Here, MAPT is linked to Alzheimer disease.